MARKER THERAPEUTICS, INC. Common Stock, Value, Issued
MARKER THERAPEUTICS, INC. (MRKR) had Common Stock, Value, Issued of $16.67 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-14
- 2026-06-30: Common Stock, Value, Issued $16.67K.
- 2026-03-31: Common Stock, Value, Issued $16.67K.
- 2025-12-31: Common Stock, Value, Issued $16.67K.
- 2025-09-30: Common Stock, Value, Issued $16.67K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $16.67K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $16.67K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $16.67K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $16.67K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $11.31K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $11.21K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $10.71K 10-K · filed 2026-03-18 | |
| 2024-09-30 | $8.92K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $8.92K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $8.91K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $8.89K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $8.89K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $8.80K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $8.80K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $8.41K 10-K · filed 2024-03-26 | |
| 2022-09-30 | $83.60K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $83.60K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $83.45K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $8.31K 10-K · filed 2023-03-22 | $83.08K 10-K · filed 2022-03-17 |
| 2021-09-30 | $83.08K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $83.08K 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $83.01K 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $50.73K 10-K · filed 2022-03-17 | |
| 2020-09-30 | $48.02K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $46.62K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $46.53K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $45.73K 10-K · filed 2021-03-09 | |
| 2019-09-30 | $45.72K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $45.51K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $45.48K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $45.44K 10-K · filed 2020-03-12 | |
| 2018-09-30 | $13.85K 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $13.62K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $10.64K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $10.62K 10-K · filed 2019-03-15 | |
| 2017-09-30 | $10.54K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $10.16K 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $8.47K 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $8.42K 10-K · filed 2018-03-23 | |
| 2016-09-30 | $8.40K 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $71.42K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $70.99K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $5.88K 10-K · filed 2017-03-14 | $70.55K 10-K · filed 2016-04-14 |
| 2015-09-30 | $62.89K 10-Q/A · filed 2016-04-14 | |
| 2015-06-30 | $38.04K 10-Q/A · filed 2016-04-14 | |
| 2015-03-31 | $32.64K 10-Q/A · filed 2016-04-14 | |
| 2014-12-31 | $20.32K 10-Q/A · filed 2016-04-14 | |
| 2014-09-30 | $19.60K 10-Q · filed 2014-11-19 | |
| 2014-06-30 | $160.02K 10-Q · filed 2014-08-18 | |
| 2014-03-31 | $159.05K 10-Q/A · filed 2014-05-21 | |
| 2013-12-31 | $1.47K 10-K · filed 2015-04-15 | $144.67K 10-K/A · filed 2014-04-17 |
| 2013-09-30 | $142.41K 10-Q · filed 2013-11-19 | |
| 2013-03-31 | $85.67K 10-Q/A · filed 2013-08-19 | |
| 2012-12-31 | $76.40K 10-K/A · filed 2014-04-17 | |
| 2012-09-30 | $73.86K 10-Q · filed 2012-11-19 | |
| 2012-06-30 | $72.86K 10-Q/A · filed 2012-09-12 | |
| 2012-03-31 | $54.33K 10-Q · filed 2012-05-21 | |
| 2011-12-31 | $52.07K 10-K · filed 2013-05-15 | |
| 2011-09-30 | $47.36K 10-Q · filed 2011-11-21 | |
| 2011-06-30 | $46.81K 10-Q · filed 2011-08-22 | |
| 2010-12-31 | $40.26K 10-K · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |